Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ambea Earnings Release 2020

Feb 16, 2021

2999_10-k_2021-02-16_dad6fbb1-fbbb-4a85-a294-67d11904b0bd.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Higher earnings despite the pandemic

Fourth quarter October-December

  • Net sales declined 1 per cent to SEK 2,764 million (2,804). Acquired growth was 2 per cent, exchange rates had a negative impact of -3 per cent on growth, and organic growth was 0 per cent.
  • Operating profit (EBIT) totalled SEK 174 million (110).
  • EBITA rose 38 per cent to SEK 200 million (145), corresponding to a margin of 7.3 per cent (5.2).
  • Adjusted EBITA, excluding items affecting comparability, rose 30 per cent to SEK 200 million (154). The adjusted EBI-TA margin was 7.3 per cent (5.5).
  • Profit for the period totalled SEK 93 million (36).
  • Earnings per share were SEK 0.98 (0.39) before and SEK 0.98 (0.39) after dilution.
  • Cash conversion was 141.4 per cent (166.3).
  • Free cash flow totalled SEK 466 million (471).

Full-year January-December

  • Net sales amounted to SEK 11,083 million (11,040). Acquired growth was 4 per cent, exchange rates had a negative impact of -3 per cent on growth, and organic growth was -1 per cent.
  • Operating profit (EBIT) totalled SEK 717 million (525).
  • EBITA rose 27 per cent to SEK 829 million (650), corresponding to a margin of 7.5 per cent (5.9).
  • Adjusted EBITA, excluding items affecting comparability, rose 12 per cent to SEK 879 million (788). The adjusted EBI-TA margin was 7.9 per cent (7.1).
  • Profit for the period totalled SEK 359 million (215).
  • Earnings per share were SEK 3.80 (2.52) before and SEK 3.80 (2.51) after dilution.
  • Cash conversion was 103.2 per cent (94.0).
  • Free cash flow totalled SEK 1,270 million (872).
  • The Board proposes that a dividend of SEK 1.15 (0) per share be paid for 2020.

Significant events

  • During the quarter, Ambea estimates the negative impact of the COVID-19 situation to be about SEK 100 million on net sales and SEK 35 million on EBITA. The negative impact includes loss of income due to lower rates of occupancy primarily in elderly care, higher costs for personal protective equipment (PPE) and sick leave, and government support received.
  • During the quarter, Mark Jensen was appointed new President and CEO of Ambea. He will assume his position on 8 March.
  • After the end of the quarter, six operations in residential and day services in Sweden were acquired from LSS Omsorgen. Ambea also concluded an agreement to acquire EKKOfonden's care operations, which provides residential care services for adults with disabilities across Denmark. Read more on pages 7 and 9.
  • The negative effects of the coronavirus pandemic on the company are expected to continue in 2021. In the first quarter, the estimated negative impact is SEK 90-100 million on sales and SEK 30-40 million on EBITA.

Consolidated key figures

SEK million 2020
Oct-Dec
2019
Oct-Dec
∆% 2020
Jan-Dec
2019
Jan-Dec
∆%
Net sales 2,764 2,804 -1 11,083 11,040 0
EBITA* 200 145 38 829 650 27
Operating margin, EBITA (%)* 7.3 5.2 7.5 5.9
Adjusted EBITA* 200 154 30 879 788 12
Operating margin, adjusted EBITA (%)* 7.3 5.5 7.9 7.1
Operating profit, EBIT 174 110 58 717 525 37
Operating margin, EBIT (%)* 6.3 3.9 6.5 4.8
Profit after tax 93 36 158 359 215 67
Earnings per share before dilution, SEK 0.98 0.39 153 3.80 2.52 51
Earnings per share after dilution, SEK 0.98 0.39 153 3.80 2.51 51
Cash conversion (%)* 141.4 166.3 103.2 94.0
Free cash flow* 466 471 -1 1,270 872 46

* Alternative performance measures. For reconciliation with IFRS financial statements, see Note 8, for purpose

and definition, see ambea.com/investor-relations/reports-and-presentations/

Comments from Benno Eliasson, Interim President and CEO

Higher earnings despite the pandemic

In the fourth quarter, the number of coronavirus cases began to rise again. We saw a second wave that is now affecting more geographic regions than the first wave. In Denmark and Norway, the number of cases and the effects on our operations were greater than last spring. Despite the widespread transmission, it was gratifying to see how the number of severe cases and deaths was lower than in the first wave in our units. We are also pleased that vaccinations have now been completed in our nursing homes and we are now moving forward with other groups.

In the fourth quarter, the estimated impact of the coronavirus is SEK -100 million on sales, and SEK -35 million on earnings. In Altiden and Stendi, the impact was greater quarter-on-quarter, while the impact in other divisions was either unchanged or slightly lower.

In the fourth quarter, net sales amounted to SEK 2,764 million (2,804). Sales were in line with the preceding year, despite a weaker NOK and lower occupancy due to the COVID-19 situation. Organic growth was 0 per cent.

Despite a second wave of COVID-19 infections, Ambea reported a strong fourth quarter with EBITA up 38 per cent to SEK 200 million. Vardaga reported stable earnings, where continuous operational improvements combined with cost reimbursements offset the negative effects of the pandemic on profitability. We are working actively to review upcoming new units and postponing start-ups where demand has been negatively affected by the pandemic. The stable profitability trend continued for Nytida due to stable occupancy and an efficient cost structure. In Stendi, positive effects from the completed restructuring programme were noted, while fourth-quarter earnings were charged with increased costs for coronavirus-related sick leave and PPE.

During the quarter, Altiden was more affected by the COVID-19 situation than previously due to a higher second wave of infections. Earnings were negatively impacted by increased costs for sick leave and PPE. At the same time, we are taking a strategic approach to the home care operations. We are planning to exit the area as contracts expire in 2021. A provision was made for termination of contracts during the quarter. At the same time, we are increasing our focus on residential care for individuals with disabilities. After the end of the fourth quarter, we announced our acquisition of EKKOfondens omsorgsverksamhet. This acquisition represents a continuation of the strategic repositioning that commenced with the acquisition of Vivamus and Casa Blanca.

In addition to the announced acquisition of EKKOfonden's care operations, Nytida completed an acquisition of six LSS units after the quarter. We would like to welcome both of these acquisitions to the Group and are looking forward to more acquisition-related activities in the year ahead.

Due to improved profit and strong cash flow for the year, our indebtedness at the end of the year was in line with Ambea's

long-term financial target. This is enabling an active acquisition agenda combined with sustainable long-term stability for our operations.

We will continue to create opportunities for future organic growth through new establishments in both elderly care and disability care. Two new nursing homes were opened in Vardaga, and three group homes and one new day services unit were opened in Nytida. At the end of the quarter, the number of beds and placements under construction was 1,931, corresponding to 21 per cent of the total number of beds and placements in operation.

The effects of the COVID-19 situation on our operations is expected to continue in the form of lower occupancy in the first quarter of 2021. We expect the impact to be SEK 90-100 million in sales, and SEK 30-40 million in EBITA.

The results from the Swedish National Board of Health and Welfare's caretaker annual survey in Nytida arrived during the quarter. It was gratifying to see that the overall satisfaction has increased among our caretakers. This gives us yet another proof that our long-term quality focus gives result. Our community engagement was acknowledged in the fourth quarter when Stendi received an award from NHO for its efforts to employ people who had been excluded from the labour market for a long time or had participated in labour market programmes.

I would like to thank all of our employees for the heroic efforts made in a challenging situation during 2020. In 2021, we are looking forward to a completed vaccination programme and fewer coronavirus cases as a result. This is a prerequisite for the operation to be able to return to a more normal state, where our focus as always will be to make the world a better place, one person at a time.

Benno Eliasson

Group

Fourth quarter

Net sales

Net sales declined 1 per cent to SEK 2,764 million (2,804). Acquired growth was 2 per cent, exchange rate effects had a negative impact of -3 per cent on growth and organic growth was 0 per cent year-on-year.

Net sales in Own Management amounted to SEK 2,062 million (2,045), up 1 per cent year-on-year, which was attributable to acquisitions and newly opened units, but offset by lower rates of occupancy due to the COVID-19 situation.

Net sales in Contract Management amounted to SEK 634 million (690). The year-onyear decline in sales was attributable to terminated elderly care contracts in Stendi, Vardaga and Altiden.

Net sales in Staffing declined 3 per cent to SEK 67 million (69).

Earnings

EBIT rose 58 per cent to SEK 174 million (110), representing a margin of 6.3 per cent (3.9).

EBITA rose 38 per cent to SEK 200 million (145). The EBITA margin was 7.3 per cent (5.2).

Adjusted EBITA for the quarter rose 30 per cent to SEK 200 million (154). Synergies achieved and operational improvements had a positive impact on earnings. A lower rate of occupancy due to the COVID-19 situation and ongoing new-starts had a negative impact on earnings. Increased costs for sick leave and PPE were partly offset by government support measures. The adjusted EBITA margin was 7.3 per cent (5.5).

Net financial items

Net financial expense was SEK -67 million (-63) for the quarter.

Income tax

Tax expense for the period was SEK 14 million (11), corresponding to an effective tax rate of 13 per cent (23).

Profit for the period

Profit for the period totalled SEK 93 million (36), corresponding to earnings per share of SEK 0.98 (0.39) before dilution and SEK 0.98 (0.39) after dilution.

Net sales by segment October – December 2020

Net sales by contract model October – December 2020

Group

January-December

Net sales

Net sales amounted to SEK 11,083 million (11,040). Acquired growth was 4 per cent, exchange rate effects had a negative impact of -3 per cent on growth and organic growth was -1 per cent year-on-year.

Net sales in Own Management amounted to SEK 8,235 million (8,029), up 3 per cent year-on-year, the result of acquisitions and start-up units.

Net sales in Contract Management amounted to SEK 2,602 million (2,719). The yearon-year decline in sales was adversely impacted by terminated elderly care contracts in Stendi and Vardaga.

Net sales in Staffing declined 16 per cent to SEK 246 million (292).

Earnings

EBIT rose 37 per cent to SEK 717 million (525), representing a margin of 6.5 per cent (4.8).

EBITA rose 27 per cent to SEK 829 million (650). The EBITA margin was 7.5 per cent (5.9).

Adjusted EBITA for the year rose 12 per cent to SEK 879 million (788). EBITA for the year was impacted by items affecting comparability of SEK -50 million (-138), attributable to costs for the restructuring programme in Norway. Completed acquisitions and synergies achieved through acquisitions had a positive impact on earnings, while lower occupancy due to the COVID-19 situation and ongoing new-starts had a negative impact. The COVID-19 situation is estimated to have affected earnings by approx. SEK -110 million related to loss of revenues and increased costs, including public compensation. The adjusted EBITA margin was 7.9 per cent (7.1).

Net financial items

Net financial expense for the period was SEK -260 million (-249). Net interest income was negatively impacted by currency effects of SEK -12 million (pos: 10) and increased IFRS-16 effects of SEK -18 million, but positively impacted by lower interest expense of SEK 20 million.

Income tax

Tax expense for the period was SEK 97 million (61), corresponding to an effective tax rate of 21 per cent (22).

Profit for the period

Profit for the period totalled SEK 359 million (215), corresponding to earnings per share of SEK 3.80 (2.52) before dilution and SEK 3.80 (2.51) after dilution.

Net sales by segment January-December 2020

Net sales by contract model January-December 2020

Cash flow

2020 2019 2020 2019
SEK million Oct-Dec Oct-Dec Jan-Dec Jan-Dec
Adjusted EBITDA 402 338 1,663 1,508
Adjustment for non-cash items 0 -38 13 -36
Change in working capital 183 273 103 15
Cash flow from investments in fixed assets -28 -24 -122 -110
Operating cash flow, including investments to increase capacity 556 550 1,657 1,377
Net financial items -67 -63 -253 -249
Tax paid -25 -7 -83 -119
Reversal of items affecting comparability 1 -9 -51 -138
Free cash flow 466 471 1,270 872
Acquisition/disposal of shares and participations 0 6 -105 -2,614
Cash flow from financing activities -486 -639 -1,178 1,739
Other 0 -5 1 -4
Cash flow for the period -20 -163 -12 -6

Free cash flow for the quarter amounted to SEK 466 million, which was in line with previous year.

Free cash flow for the period amounted to SEK 1,270 million (872). The increase was largely due to improved earnings and reduced tied-up working capital.

Financial position

SEK million 31 Dec
2020
31 Dec
2020
excl. IFRS 16
31 Dec
2019
31 Dec
2019
excl. IFRS 16
Net interest-bearing debt* 8,375 2,672 7,917 3,213
Rolling 12 months adjusted EBITDA* 1,663 862 1,508 796
Net debt/Rolling 12 months adjusted EBITDA 5.0 3.1 5.3 4.0

At 31 December 2020, net interest-bearing debt amounted to SEK 8,375 million (7,917). Indebtedness, excluding IFRS 16 effects, declined SEK 541 million to SEK 2,672 million, or 3.1 times (4.0) 12-months adjusted EBITDA. The strong cash flow for the year had a positive impact on the company's financial position.

* Alternative performance measures. For reconciliation with IFRS financial statements, purpose and definition, seeambea.com/investor-relations/reports-and-presentations/

Vardaga

At Vardaga's just over 100 residential care facilities across Sweden, we provide elderly care where every day is as meaningful as the next. Every one of our nursing homes, short-term accommodation and home care units offers a high level of expertise and safety. Our employees ensure quality of life and safety for every care receiver.

Quarter

Vardaga's net sales declined 5 per cent year-on-year to SEK 867 million (915).

Net sales in Own Management amounted to SEK 548 million (554), down 1 per cent, the result of generally lower occupancy rates due to the COVID-19 situation.

Net sales in Contract Management amounted to SEK 319 million (361). The 11 per cent decline was due to terminated contracts. During the quarter, Vardaga retained existing contracts amounting to an annual volume of SEK 9 million.

EBITA rose 8 per cent to SEK 42 million (39). As in the preceding quarter, earnings were adversely impacted by lower occupancy rates due to the coronavirus pandemic combined with a high start-up rate. Retroactive reimbursement of additional costs linked to the COVID-19 situation had a positive effect of SEK 20 million. Earnings were also strengthened by continuous operational improvements in the acquired Aleris Omsorg operations. Increased costs for sick leave and PPE were offset by government support measures.

The EBITA margin was 4.8 per cent (4.3). The EBITA margin for mature units (opened before 2019) declined 0.4 percentage points, mainly the result of lower occupancy due to the COVID-19 situation.

January – December period

Vardaga's net sales amounted to SEK 3,497 million (3,494), in line with the year-earlier period.

Net sales in Own Management amounted to SEK 2,184 million (2,061), a 6 per cent increase attributable to the acquisition of Aleris Omsorg and newly opened units, but offset by lower occupancy rates due to the COVID-19 situation.

Net sales in Contract Management amounted to SEK 1,313 million (1,433). The 8 per cent decline was due to terminated contracts.

EBITA declined 26 per cent to SEK 154 million (207). The lower profitability was attributable to lower occupancy due to the coronavirus pandemic and new start-up units.

The EBITA margin was 4.4 per cent (5.9).

Vardaga adjusted EBITA margin RTM* %

Total Vardaga Mature units (opened before 2019)

SEK million 2020
Oct-Dec
2019
Oct-Dec

%
2020
Jan-Dec
2019
Jan-Dec

%
Net sales 867 915 -5 3,497 3,494 0
EBITA* 42 39 8 154 207 -26
Operating margin, EBITA (%)* 4.8 4.3 4.4 5.9
Operating margin, EBITA mature units (%)* 10.7 11.1 9.1 12.4

Nytida

Nytida provides support and care for children, young people and adults with lifelong disabilities and psychosocial problems. We provide residential care, day services, support for individuals and families, and schools in approximately 400 units across Sweden. Using proven models and in-depth knowledge, our 8,500 employees help to strengthen the ability of individuals to live an independent life.

Quarter

Net sales rose 3 per cent to SEK 946 million (919).

Net sales in Own Management amounted to SEK 786 million (787).

Net sales in Contract Management amounted to SEK 160 million (132). The 21 per cent increase was due to start-ups of previously won contracts. During the quarter, Nytida secured new contracts corresponding to an annual volume of SEK 33 million.

Adjusted EBITA rose 33 per cent to SEK 159 million (120). Earnings were positively impacted by synergies achieved and efficiency improvements. Retroactive reimbursement of costs related to the COVID-19 situation had a positive impact on earnings.

The adjusted EBITA margin was 16.8 per cent (13.1).

After the end of the quarter, six operations in residential and day services for adults with disabilities were acquired from LSS Omsorgen. The acquisition was transferred on 1 February 2021.

January – December period

Net sales increased to SEK 3,701 million (3,664).

Net sales in Own Management amounted to SEK 3,100 million (3,173), down 2 per cent. Units discontinued in 2019 had a negative impact on sales. The full-year effect of the acquisition of Aleris Omsorg and start-up units made a positive contribution.

Net sales in Contract Management amounted to SEK 601 million (491), up 22 per cent due to start-ups of previously won contracts.

EBITA rose 18 per cent to SEK 604 million (512). Synergies achieved through the acquisition of Aleris Omsorg, and government support measures during the coronavirus pandemic, made a positive contribution.

The EBITA margin was 16.3 per cent (14.0).

SEK million 2020
Oct-Dec
2019
Oct-Dec

%
2020
Jan-Dec
2019
Jan-Dec

%
Net sales 946 919 3 3,701 3,664 1
EBITA* 159 120 33 604 512 18
Operating margin, EBITA (%)* 16.8 13.1 16.3 14.0

Stendi

Stendi is the largest care provider in Norway and runs nationwide operations in support and residential care for adults, children and young people. We also offer personal assistance, elderly care and home care. We have about 5,000 employees and more than 400 units across Norway.

Quarter

Net sales declined 6 per cent to SEK 726 million (770). In local currency, sales rose 4 per cent year-on-year.

Net sales in Own Management amounted to SEK 672 million (689), down 2 per cent.

Net sales in Contract Management amounted to SEK 53 million (81), where the lower sales were due to elderly care contracts that were previously handed back.

Adjusted EBITA was SEK 15 million (-2). Earnings were positively impacted by ongoing efforts to introduce Ambea's operational management model, but were burdened with currency effects. The effects of completed restructuring programme had a positive impact on earnings but were offset by increased costs for coronavirus-related sick leave and PPE.

The adjusted EBITA margin was 2.0 per cent (-0.3).

January – December period

Net sales amounted to SEK 2,975 million (3,106). In local currency, growth was 5 per cent. The increase was attributable to the full-year effects of the acquisition of Aleris Omsorg.

Net sales in Own Management amounted to SEK 2,726 million (2,736). In local currency, growth was 10 per cent.

Net sales in Contract Management amounted to SEK 249 million (370). The decline in sales was attributable to handed-back contracts in elderly care.

Adjusted EBITA was SEK 137 million (80). The increase was attributable to lower costs for temporary staff and increased staffing efficiency. In the first quarter, a major restructuring programme commenced, with the aim of strengthening the margin by centralising support functions and strengthening local leadership. Items affecting comparability of SEK 50 million were charged to the period. The programme achieved full effect at the end of 2020.

The adjusted EBITA margin was 4.6 per cent (2.6).

SEK million 2020
Oct-Dec
2019
Oct-Dec

%
2020
Jan-Dec
2019
Jan-Dec

%
Net sales 726 770 -6 2,975 3,106 -4
Adjusted EBITA* 15 -2 n.a. 137 80 70
Operating margin, adjusted EBITA (%)* 2.0 -0.3 4.6 2.6

Altiden

Altiden is the largest private care provider in Denmark, with operations comprising elderly care, home care, rehabilitation and disability care. All over Denmark, we provide skilled care services based on respect. Approximately 1,000 employees ensure quality of life and a safe environment with a focus on development.

Quarter

Net sales rose 21 per cent to SEK 158 million (131).

Net sales in Own Management amounted to SEK 56 million (20). The increase in sales was attributable to acquisitions.

Net sales in Contract Management amounted to SEK 102 million (111), where the decline was attributable to the termination of one nursing home contract at the beginning of the quarter and lower demand in home care.

EBITA was SEK -16 million (0). EBITA was charged with costs of SEK 10 million for the home care operations, which includes a provision for termination of contracts. Increased costs for the COVID-19 situation in both disability care and nursing homes had a negative impact on earnings. Acquired units (Casablanca Bo & Ehrverv ApS and Vivamus A/S) performed as planned, which had a positive impact on earnings.

The EBITA margin was -10.1 per cent (0.0).

After the end of the quarter, Ambea announced that Altiden had acquired EKKOfonden's care operations, which provides residential care services for young people and adults with disabilities. EKKOfonden is one of Denmark's largest social care providers with operations across the entire country. The takeover will take the form of an asset acquisition, with transfer scheduled for the second quarter of 2021.

January – December period

Net sales amounted to SEK 663 million (484). The increase was attributable to acquisitions completed by early 2020, and the full-year effects of the acquisition of Aleris Omsorg.

Net sales amounted to SEK 225 million (59) in Own Management, and SEK 438 million (425) in Contract Management.

EBITA was SEK -14 million (-12). EBITA was positively impacted by completed acquisitions, but charged with higher costs for building up a separate organisation in Altiden. EBITA was charged with higher costs for the home care operations, which include a provision for termination of contracts.

The EBITA margin was -2.1 per cent (-2.5).

Altiden adjusted EBITA margin RTM* %

SEK million 2020
Oct-Dec
2019
Oct-Dec

%
2020
Jan-Dec
2019
Jan-Dec

%
Net sales 158 131 21 663 484 37
EBITA* -16 0 n.a. -14 -12 17
Operating margin, EBITA (%)* -10.1 0.1 -2.1 -2.5

Klara

Klara is one of Sweden's leading providers of staffing services for social care. We are an authorised staffing company and are ISO certified. With personal service and long experience in the industry, Klara provides the best staffing solutions for both public and private clients. We offer ambulatory care teams and temporary doctors, nurses and other care workers, in Sweden.

Quarter

Net sales declined 3 per cent to SEK 67 million (69). The decrease was attributable to a negative trend in temporary staffing services to the private customer segment due to the introduction of VAT liability for sales in July 2019.

EBITA was SEK 7 million (7), representing a margin of 10.4 per cent (10.1). The margin was positively impacted by a stable trend for ambulatory care teams, but charged with higher personnel costs due to the COVID-19 situation.

January-December period

Net sales declined 16 per cent to SEK 246 million (292). The decrease was attributable to a negative trend, particularly for temporary doctors and nurses.

EBITA was SEK 26 million (25), representing a margin of 10.6 per cent (8.6). Increased profitability in ambulatory care teams and the effects of previously completed administrative cost adjustments made a positive contribution.

Klara adjusted EBITA margin RTM**, %

SEK million 2020
Oct-Dec
2019
Oct-Dec

%
2020
Jan-Dec
2019
Jan-Dec

%
Net sales 67 69 -3 246 292 -16
EBITA* 7 7 0 26 25 4
Operating margin, EBITA (%)* 10.4 10.1 10.6 8.6

Operational key figures

SEK million 2019
Q4
2020
Q1
2020
Q2
2020
Q3
2020
Q4
Ambea
Number of beds and placements in operation under own management on the
closing date
8,637 8,832 9,089 9,036 9,160
Number of beds and placements opened under own management (RTM) 562 600 668 610 643
Number of beds and placements under own management under construction,
on the closing date
2,309 2,181 2,057 1,950 1,931
Net won/lost management contracts, annual volume SEK million* -28 157 -90 0 33
Vardaga
Number of beds in operation under own management on the closing date
2,545 2,661 2,848 2,792 2,885
Number of beds opened under own management (RTM) 477 521 564 504 511
Number of beds under own management under construction on the closing
date
1,983 1,867 1,790 1,686 1,628
Net won/lost management contracts, annual volume SEK million* -36 157 -24 0 0
Nytida
Number of beds and placements in operation under own management on the
closing date
5,138 5,150 5,220 5,220 5,275
Number of beds and placements opened under own management (RTM) 77 71 104 98 124
Number of beds and placements under own management under construction,
on the closing date
249 237 190 187 151
Net won/lost management contracts, annual volume SEK million* 8 0 -9 0 33
Stendi
Number of beds in operation under own management on the closing date
868 871 871 866 842
Number of beds opened under own management (RTM) 3 3 0 0 0
Number of placements under own management under construction on the
closing date
0 0 0 0 0
Net won/lost management contracts, annual volume SEK million* 0 0 0 0 0
Altiden
Number of beds and placements in operation under own management on the
closing date
86 150 150 158 158
Number of beds opened under own management (RTM) 5 5 0 8 8
Number of beds and placements under own management under construction,
on the closing date
77 77 77 77 152
Net won/lost management contracts, annual volume SEK million* 0 0 -57 0 0

* Includes management contracts to be retaken.

Other events

Legal proceeding regarding social security costs for temporary staff in Norway

Since the first quarter of 2019, through the acquisition of the Aleris Omsorg operations, Ambea has been involved in an ongoing legal proceeding in Norway regarding costs for temporary staff. Ambea's exposure due to this procedure is limited to NOK 30 million, which has been reserved as a provision in the combined companies' balance sheet.

In the third quarter of 2019, the District Court pronounced its decision. Of the 24 parties involved in the legal proceeding, two were considered entitled to social security benefits for previously delivered services. Since the acquisition of Aleris Care, Ambea has continued the process of reducing the use of consultants and uses preferably fixed employees in the operations today.

Tax audit in Sweden

In 2018, Ambea received a reassessment notice from the Swedish Tax Agency regarding VAT of SEK 12 million, including tax surcharges, for prior years in Ambea AB (publ). The reassessment was mainly related to input VAT on costs arising from the IPO in 2017. The company has appealed against the Swedish Tax Agency's preliminary decision and is awaiting further assessment in the Administrative Court, which is why no provision has been made for the cost.

Legal dispute in Norway

In the fourth quarter of 2019, lawsuits were filed against Ambea citing the previously communicated irregularities in Norway, which are described in the Q1 report for 2019. The dispute concerns circumstances that existed prior to the acquisition of Aleris Omsorg's operations in Norway, and estimated costs associated with the case have already been reserved in the combined companies' balance sheet.

Related-party transactions

During the quarter, no transactions took place between Ambea and its related parties that had any material impact on the company's position and earnings. The nature and volume of transactions remained unchanged during the period compared with the preceding year.

Events after the end of the quarter

After the end of the quarter, six operations in residential and day services for adults with disabilities in Sweden were acquired from LSS Omsorgen. Ambea also concluded an agreement to acquire EKKOfondens omsorgsverksamhet, which provides residential care services for adults with disabilities across Denmark. Read more on pages 7 and 9

Seasonal variations

Ambea's operating profit is affected by seasonal variations, weekends and public holidays.

Weekends and public holidays reduce Ambea's profitability due to higher personnel costs for inconvenient working hours. Most of the public holidays in countries where the company operates normally fall in the second quarter. In some years, Easter may fall in the first quarter and then affect its profitability. Christmas and New Year affect the first and fourth quarters.

The company's personnel costs are similarly affected when employees take out their holidays. For example, the company is most profitable in the third quarter, as employees usually take their holidays during July and August and therefore receive holiday pay that is continuously accrued throughout the year. Costs during the summer months are also generally lower due to a reduced schedule for central activities, such as mandatory training programmes and central initiatives, during this period.

Employees

During the period, the average number of full-time employees (FTEs) was 13,794 (13,214), and the increase was mainly due to acquisitions and start-up units.

Risks and uncertainties

Ambea is exposed to a variety of risks and attaches great importance to continuously analysing, minimising and managing these risks. The risk assessment is also central to the annual strategy process, where specific risks in relation to the company's ability to achieve its financial targets and strategic ambitions are evaluated. Ambea has identified the following risks: brand risks, industry and market risks, compliance and legal risks, operational risks and financial risks. For a description of these risks and how they are managed, refer to pages 48–49 of the 2019 Annual Report.

In addition to the above, the COVID-19 situation entails a risk for Ambea. The COVID-19 situation primarily affects occupancy and the ability to staff our operations. We are working actively to manage and limit these risks with structured support from Ambea's crisis organisation. Lower occupancy is the risk with the greatest potential financial impact in the short term. COVID-19 is a unique phenomenon because the impact is difficult to assess and the future trend is unpredictable.

Key judgements and estimates

For information about the key judgements and estimates in this year-end report, refer to Note G32 in the company's 2019 Annual Report.

Other information

This company's auditors have not reviewed this report.

The Board of Directors' assurance

The Board of Directors and Chief Executive Officer hereby provide their assurance that this year-end report provides a true and fair view of the operations, position and earnings of the Parent Company and the Group, and describes the material risks and uncertainties facing the Parent Company and the companies in the Group.

Stockholm, 15 February 2021

Lena Hofsberger Chair of the Board

Daniel Björklund Lars Gatenbeck Board member Board member

Liselott Kilaas Gunilla Rudebjer Mikael Stöhr Board member Board member Board member

Patricia Briceño Charalampos Kalpakas Magnus Sällström Employee representative Employee representative Employee representative

Benno Eliasson Interim President and CEO

Presentation of the fourth quarter of 2020

Ambea will hold a presentation for the financial market, with the possibility to participate by teleconference, at 10:00 a.m. CET on Tuesday, 16 February 2021. The presentation will be held in English, and be available as a webcast at ambea.se

Call-up information

To make sure that the hook-up to the conference call works, please call at least five minutes before the conference call's start time to register, or use the code: 7444318.

Phone numbers

Sweden: +46 (0)8 506 921 80
UK: +44 (0)20 71 92 80 00
US: +1 63 15 10 74 95

Contact

Jacob Persson, Head of Group Business Control & Investor Relations Tel: +46 (0)708 64 07 52

Forthcoming report occasions

Annual Report 29 March
Q1 interim report 4 May 2021
Annual General Meeting 12 May
Q2 interim report 23 July 2021
Q3 interim report 4 November 2021

Annual General Meeting, 12 May

The 2020 AGM will be held on 12 May at 10:00 a.m. in Ambea's head office, Evenemangsgatan 21, in Solna, Sweden.

Shareholders who wish to have a matter addressed by the AGM must submit a written request to [email protected] or by post to:

Ambea AB Att: Jacob Persson Box 1565 SE-171 29 Solna Sweden

The Board of Directors must receive the request by 19 March.

Ambea is the leading private care company in Sweden, Norway and Denmark, with more than 900 units and approximately 26,000 employees. Within our group of companies, we provide residential facilities, support, education and social care staffing. We aim to be the quality leader in all that we do and our vision is to make the world a better place, one person at a time. The company was founded in 1996, is headquartered in Solna and listed on Nasdaq Stockholm. www.ambea.se

Consolidated earnings in summary

2020 2019 2020 2019
SEK million Oct-Dec Oct-Dec Jan-Dec Jan-Dec
Operating income
Net sales 2,764 2,804 11,083 11,040
Other operating income 70 37 122 99
Total operating income 2,834 2,841 11,205 11,139
Operating expenses
Consumables -99 -71 -358 -383
Other external costs -320 -398 -1,260 -1,532
Personnel costs -2,012 -2,042 -7,973 -7,851
Depreciation, amortisation and impairment of fixed assets -228 -219 -896 -845
Other operating expenses -2 -1 -1 -3
Operating expenses -2,660 -2,731 -10,488 -10,614
Operating profit 174 110 717 525
Financial income 0 2 1 12
Financial expenses -67 -65 -261 -261
Net financial items -67 -63 -260 -249
Profit after net financial items 107 47 457 276
Profit before tax 107 47 457 276
Tax on profit for the period -14 -11 -97 -61
Profit for the period 93 36 359 215
Profit for the period attributable to shareholders of the Parent Company 93 36 359 215
Earnings per share before dilution, SEK 0.98 0.39 3.80 2.52
Earnings per share after dilution, SEK 0.98 0.39 3.80 2.51

Consolidated statement of comprehensive income in summary

SEK million 2020
Oct-Dec
2019
Oct-Dec
2020
Jan-Dec
2019
Jan-Dec
Profit for the period after tax 93 36 359 215
Other comprehensive income, items not transferable to profit or loss
Remeasurement of defined-benefit pension plans
3 3 -6 -9
Tax related to remeasurement of defined-benefit pension plans -1 2 1 2
Total items not transferable to profit or loss 2 5 -5 -7
Other comprehensive income, items transferable to profit or loss
Translation differences
-4 -25 -95 -13
Hedging of net investments in foreign operations -1 5 46 -7
Cash flow hedges 4 1 -9 2
Hedging cost reserve 0 0 1 -4
Tax -0 -1 -8 2
Total items transferable to profit or loss -2 -21 -65 -19
Total other comprehensive income -0 -15 -69 -25
Total comprehensive income for the period 93 21 290 190
Comprehensive income for the period attributable to shareholders of the Parent Company 93 21 290 190

Earnings per share

2020
Oct-Dec
2019
Oct-Dec
2020
Jan-Dec
2019
Jan-Dec
Profit for the period attributable to shareholders of the Parent Company, SEK million 93 36 359 215
Earnings per share before dilution
Average number of shares, thousands
Earnings per share before dilution, SEK
94,484
0.98
94,473
0.39
94,466
3.80
85,727
2.52
Earnings per share after dilution
Average number of shares, thousands
Earnings per share after dilution, SEK
94,548
0.98
94,585
0.39
94,531
3.80
85,837
2.51

Consolidated balance sheet in summary

SEK million 2020
31 Dec
2019
31 Dec
Assets
Fixed assets
Goodwill 6,508 6,532
Customer contracts and customer relationships 496 607
Other intangible assets 27 24
Right-of-use assets 5,675 4,698
Tangible assets 270 251
Derivative instruments 2 3
Deferred tax assets 72 54
Non-current receivables 99 101
Total fixed assets 13,148 12,270
Current assets
Inventories 0 0
Accounts receivable 1,078 1,078
Other receivables 93 67
Prepaid expenses and accrued income 291 261
Cash and cash equivalents 25 52
Total current assets excluding assets held for sale 1,487 1,458
Assets held for sale 83 82
Total current assets 1,570 1,540
Total assets 14,718 13,810

Consolidated balance sheet in summary – continuation

SEK million 2020
31 Dec
2019
31 Dec
Equity and liabilities
Equity
Share capital 2 2
Other capital contributions 6,167 6,167
Reserves -82 -19
Retained earnings including profit for the year -1,762 -2,114
Total equity attributable to shareholders of the Parent Company 4,326 4,036
Non-controlling interests
Total equity 4,326 4,036
Non-current liabilities
Non-current interest-bearing liabilities 766 961
Lease liabilities 5,167 4,170
Derivative instruments 7
Pension provisions 38 39
Other provisions 38 48
Deferred tax liabilities 186 173
Total non-current liabilities 6,203 5,390
Current liabilities
Commercial papers 1,813 2,228
Lease liabilities 655 610
Accounts payable 311 266
Tax liabilities 80 53
Other non-interest-bearing liabilities 182 200
Accrued expenses and deferred income 1,149 1,027
Total current liabilities 4,190 4,384
Total equity and liabilities 14,718 13,810

Consolidated statement of changes in equity in summary

2020 2019
SEK million Jan-Dec Jan-Dec
Opening balance 4,036 2,725
Comprehensive income 290 190
Transactions with shareholders
Warrants issued
2
Share buybacks -5
New share issue 1,213
Issue expenses -15
Dividends -74
Closing balance 4,326 4,036

Consolidated cash flow statement in summary

SEK million 2020
Oct-Dec
2019
Oct-Dec
2020
Jan-Dec
2019
Jan-Dec
Operating activities
Profit before tax 107 47 457 276
Adjustment for non-cash items 229 181 916 810
Cash flow from operating activities before working capital and tax 336 228 1,373 1,087
Tax paid -25 -7 -83 -119
Cash flow from operating activities before changes in working capital 312 222 1,289 968
Cash flow from changes in working capital
Change in operating receivables
-2
90
-70 70
Change in operating liabilities 185 183 173 -55
Cash flow from operating activities 494 495 1,392 982
Investing activities
Investment in intangible assets -2
-1
-12 -7
Investment in tangible assets -26 -23 -112 -115
Divestment of tangible assets
3 11
Free cash flow 466 471 1,270 872
Acquisition and disposal of shares and participations
6
-105 -2,614
Other financial assets
-1
-0 -4
Cash flow from investing activities -28 -19 -226 -2,729
Cash flow after investments 466 476 1,166 -1,746
Financing activities
New loans/Loans raised 1,889 832 6,037 8,911
Repayment of loan liabilities -1,706 -1,431 -6,170 -6,221
Repayment of lease liability -160 -138 -643 -581
Change in revolving credit facility -509 103 -403 -1,492
New share issue
1,200
Premiums for warrants
2
Share buybacks
-5
-5
Dividends paid
-74
Cash flow from financing activities -486 -639 -1,178 1,739
Cash flow for the period -20 -163 -13 -6
Cash and cash equivalents on the opening date 52
215
52 62
Exchange rate differences in cash and cash equivalents -7
-0
-14 -4
Cash and cash equivalents on the closing date 25 52 25 52

Parent Company income statement in summary

SEK million 2020
Oct-Dec
2019
Oct-Dec
2020
Jan-Dec
2019
Jan-Dec
Income
Net sales
2 3 8 17
Total income 2 3 8 17
Operating expenses
Other external costs -2 -3 -9 -15
Personnel costs -4 -3 -14 -16
Amortisation of intangible assets -0 -0 -0 -0
Operating expenses -5 -6 -23 -32
Operating loss -4 -3 -15 -15
Financial items -6 -2 -29 -59
Loss after financial items -10 -4 -44 -74
Appropriations 96 199 96 199
Profit before tax 86 194 51 124
Tax on profit for the period -11 -27 -11 -27
Profit for the period 74 168 40 98

Parent Company balance sheet in summary

SEK million 2020
31 Dec
2019
31 Dec
Assets
Intangible assets
Software 1 1
Financial assets
Participations in Group companies 7,210 7,208
Derivative assets 4 3
Total fixed assets 7,215 7,213
Current assets
Receivables from Group companies*
3,156 2,555
Other receivables 16 12
Tax assets
Prepaid expenses and accrued income 8 11
Cash and bank balances 0 0
Total current assets 3,180 2,579
Total assets 10,394 9,792
Equity and liabilities
Share capital 2 2
Statutory reserve 0 0
Total restricted equity 3 2
Share premium reserve 1,404 1,403
Retained earnings 1,869 1,771
Profit for the period 40 98
Total non-restricted equity 3,313 3,272
Total equity 3,316 3,274
Untaxed reserves 50 33
Non-current liabilities
Liabilities to credit institutions* 814 965
Total non-current liabilities 814 965
Current liabilities
Commercial papers 1,813 2,228
Accounts payable 4 1
Tax liabilities 32 20
Liabilities to Group companies* 4,352 3,253
Other liabilities 0 0
Accrued expenses and deferred income 12 17
Total current liabilities 6,214 5,520
Total equity and liabilities 10,394 9,792

* As of the fourth quarter of 2019, the entire cash pool has been recognised as a liability in the Parent Company. The Group's indebtedness has not been impacted. The comparative figures have been restated for comparability.

Notes

NOTE 1 Accounting policies

This year-end report has been prepared in accordance with IAS 34 Interim Financial Reporting and the Swedish Annual Accounts Act, as well as the Swedish Financial Reporting Board's RFR 1, Supplementary Accounting Rules for Groups, and RFR 2 Accounting for Legal Entities. The accounting policies applied are consistent with those applied in the preparation of the most recent annual report.

New or revised IFRS standards from 2020

None of the new or revised standards or interpretations, which were applicable from 1 January 2020, had any material impact on the financial statements of the Group or the Parent Company. No new or revised standards have been adopted in advance.

Alternative performance measures

In the preceding year, alternative performance measures were presented adjusted for the effects of the adoption of IFRS 16 to enable a comparison with 2018. As comparability exists between 2020 and 2019, no such adjusted measures are now presented, apart from Net debt/Rolling 12 months adjusted EBITDA, which pertains to the covenant for the revolving credit facility and the Group's EBITA and EBITDA.

As of the first quarter of 2020, disclosures are no longer provided for the EBITDA margin, adjusted EBITDA margin, equity/assets ratio or return on equity. These alternative performance measures have been excluded as management does not use the measures in its monitoring and control of the operations. Management monitors operations at adjusted EBITA level, and for this reason items affecting comparability have been allocated to the extent they can be derived from a specific division and operating segment. The comparative year has been restated.

NOTE 2 Segment information

Ambea's operations consist of the following segments:

Vardaga Comprises nursing homes, short-term accommodation units, home care
and day services for the elderly in Sweden.
  • Nytida Comprises residential facilities, day services, support for individuals and families, and schools for children, young people and adults with disabilities or psychosocial issues in Sweden.
  • Stendi Comprises support for children, young people and adults by offering personal assistance, residential care, elderly care and home care in Norway.
  • Altiden Comprises operations in elderly care, home care, social care and disability care in Denmark.
  • Klara Comprises subscription services for ambulatory care nurses and temporary doctors and nurses in Sweden.

NOTE 2 Segment information – continuation

October – December 2020

Unallocated Group
SEK million Vardaga Nytida Stendi Altiden Klara items* adjustments Group
Operating income
Net sales 867 946 726 158 67 0 0 2,764
Other operating income 38 20 4 1 22 7 -22 70
Internal transactions -22 22 0
Total income from external customers 904 966 730 159 67 7 0 2,834
EBITA 42 159 15 -16 7 -7 0 200
EBITA margin, % 4.8 16.8 2.1 -10.1 10.4 7.3
Items affecting comparability 0 0 -0
Adjusted EBITA 42 159 15 -16 7 -7 0 200
Adjusted EBITA margin, % 4.8 16.8 2.0 -10.1 10.4 7.3
Amortisation of intangible assets -27
Operating profit (EBIT) 174
Net financial items -67
Profit after net financial items 107
Profit before tax 107
Tax on profit for the period -14
Profit for the period 93
Assets 6,405 5,729 1,836 452 178 118 14,718

October – December 2019

Unallocated Group
SEK million Vardaga Nytida Stendi Altiden Klara items* adjustments Group
Operating income
Net sales
915 919 770 131 69 0 2,804
Other operating income 8 8 14 1 16 6 -16 37
Internal transactions -16 16 0
Total income from external customers 923 927 783 132 69 6 2,841
EBITA 39 120 -6 0 7 -15 145
EBITA margin, % 4.3 13.1 -0.8 0.0 10.1 5.2
Items affecting comparability 4 5 9
Adjusted EBITA 39 120 -2 0 7 -10 154
Adjusted EBITA margin, % 4.3 13.1 -0.3 0.0 10.1 5.5
Amortisation of intangible assets -35
Operating profit (EBIT) 110
Net financial items -63
Profit after net financial items 47
Profit before tax 47
Tax on profit for the period -11
Profit for the period 37
Assets 5,257 5,905 2,069 246 180 153 13,810

* The 'Unallocated items' column consists of centrally approved costs for general central administration, restructures and acquisitions.

NOTE 2 Segment information – continuation

January – December 2020

Unallocated Group
SEK million Vardaga Nytida Stendi Altiden Klara items* adjustments Group
Operating income
Net sales 3,497 3,701 2,975 663 246 11,083
Other operating income 55 37 11 2 83 15 -83 122
Internal transactions -83 83 0
Total income from external customers 3,552 3,738 2,986 666 246 15 0 11,205
EBITA 154 604 86 -14 26 -28 829
EBITA margin, % 4.4 16.3 2.9 -2.1 10.6 7.5
Items affecting comparability 50 50
Adjusted EBITA 154 604 137 -14 26 -28 879
Adjusted EBITA margin, % 4.4 16.3 4.6 -2.1 10.6 7.9
Amortisation of intangible assets -112
Operating profit (EBIT) 717
Net financial items -260
Profit after net financial items 457
Profit before tax 457
Tax on profit for the period -97
Profit for the period 359
Assets 6,405 5,729 1,836 452 178 118 14,718

January – December 2019

Unallocated Group
SEK million Vardaga Nytida Stendi Altiden Klara items* adjustments Group
Operating income
Net sales
3,494 3,664 3,106 484 292 11,040
Other operating income 20 19 41 2 50 17 -50 99
Internal transactions -50 50
Total income from external customers 3,514 3,684 3,147 485 292 17 11,139
EBITA 207 512 44 -12 25 -126 650
EBITA margin, % 5.9 14.0 1.4 -2.5 8.6 0 5.9
Items affecting comparability 36 4 98 138
Adjusted EBITA 207 512 80 -8 25 -28 788
Adjusted EBITA margin, % 5.9 14.0 2.6 -1.6 8.6 7.1
Amortisation of intangible assets -125
Operating profit (EBIT) 525
Net financial items -249
Profit after net financial items 276
Profit before tax 276
Tax on profit for the period -61
Profit for the period 215
Assets 5,257 5,905 2,069 246 180 153 13,810

* The 'Unallocated items' column consists of centrally approved costs for general central administration, restructures and acquisitions.

NOTE 3 Revenue from Contracts with Customers

Type of service delivery (October – December)

Vardaga Nytida Stendi Altiden Klara Group
SEK million 2020 2019 2020 2019 2020 2019 2020 2019 2020 2019 2020 2019
Own Management 548 554 786 787 672 689 56 20 2,062 2,050
Contract Management 319 361 160 132 53 81 102 111 634 685
Staffing 67 69 67 69
Total 867 915 946 919 726 770 158 131 67 69 2,764 2,804

Type of service delivery (January – December)

Vardaga Nytida Stendi Altiden Klara Group
SEK million 2020 2019 2020 2019 2020 2019 2020 2019 2020 2019 2020 2019
Own Management 2,184 2,061 3,100 3,173 2,726 2,736 225 59 8,235 8,029
Contract Management 1,313 1,433 601 491 249 370 438 425 2,602 2,719
Staffing 246 292 246 292
Total 3,497 3,494 3,701 3,664 2,975 3,106 663 484 246 292 11,083 11,040

NOTE 4 Items affecting comparability

SEK million 2020
Oct-Dec Oct-Dec
2019 2020
Jan-Dec
2019
Jan-Dec
Restructuring and acquisition-related items 0 -9 -50 -138
Total items affecting comparability 0 -9 -50 -138

Items affecting comparability in 2020 relate to the restructuring programme in Norway, which was announced in the year-end report for 2019. In 2019, items affecting comparability related to integration and synergy-realisation costs in connection with the acquisition of Aleris Omsorg, and the restructure of Nytida.

Note 5 Business combinations

During the year, Ambea completed the acquisition of Vivamus A/S. The consideration (purchase price) transferred for the acquisition comprised cash in the amount of SEK 149 million. The acquisition generated goodwill of SEK 121 million, corresponding to the difference between the consideration transferred and the identifiable net assets acquired. The goodwill mainly relates to a stronger market position and

operative and administrative synergies. The acquisition analysis was finalised in the third quarter. Since the acquisition date, Vivamus has contributed SEK 121 million to net sales, and SEK 10 million to profit before tax. If the acquisition had taken place on 1 January 2020, the company would have contributed SEK 123 million to net sales and SEK 11 million to profit before tax.

Effect on financial position

SEK million 2020
Identifiable intangible assets
Identifiable net assets excl. intangible assets 28
Group goodwill 121
Total consideration (price of shares) 149
Net change in cash 102

Distribution of net assets on the acquisition date

SEK million 2020
Fixed assets 3
Right-of-use assets 57
Accounts receivable and other receivables 11
Cash and cash equivalents 47
Non-current liabilities and provisions
Lease liabilities 57
Accounts payable and other liabilities 34
Identifiable net assets 28

NOTE 5 Business combinations – continuation

Acquisitions and divestments during the year
Date Acquisitions Divestments Operations Segments Annual sales
8 Jan 2020 Vivamus AS Residential care for people with disabilities Altiden DKK 80 million
1 Feb 2020 Nacka Hemtjänst Home-care operations in Nacka (business transfer) Vardaga SEK 25 million

NOTE 6 Fair value of financial instruments in the fair value hierarchy

Classification in the fair value hierarchy
1 2 3
2020 2019 2020 2019 2020 2019 2020 2019
SEK million 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec
Assets
Interest-rate derivatives 2 3 2 3
Liabilities
Interest-rate derivatives 7 7
Earn-out 1 1

Fair value of financial instruments in the fair value hierarchy

Ambea applies the following hierarchy for the fair value measurement of financial instruments:

Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities. This level includes Eligible treasury bills, Bonds and Other interest-bearing securities. Remeasurement is recognised in Net financial items.

Level 2 – Observable data for assets or liabilities other than quoted prices included in Level 1, either directly (i.e. as price quotations) or indirectly (i.e. derived from price quotations). This level includes derivative instruments that are recognised under Other current assets or Other current liabilities.

Level 3 – Data for assets or liabilities not based on observable market data.

Ambea has loans denominated in both SEK and NOK and is thereby exposed to interest-rate risk. According to the company's financial policy, at least 50 per cent of the interest-rate risk should be hedged. To reduce the company's interest-rate risk, the company purchased an interest-rate swap and an interest rate cap in March 2019, both with three-year maturities. In the second quarter, these were extended to four years and will mature in 2024. In total, 60 per cent of the interest-rate risk was hedged with interest-rate derivatives on the balance-sheet date.

Derivatives are classified as Level 2 assets in the fair value hierarchy. The change in fair value of the interest-rate cap and interest-rate swap was recognised in other comprehensive income. Ambea uses standard bank pricing models for the valuation of purchased interest-rate caps and interest-rate swaps. The valuation is based on the bank's standard pricing model and methodology. The valuation is based on the bank's average price.

Note 7 Pledged assets and contingent liabilities

SEK million 2020
31 Dec
2019
31 Dec
Leased assets 115 66
Chattel mortgages 1 7
Real estate mortgages 9
Total pledged assets 116 82

* For distribution by line in profit or loss, see ambea.com/investor-relations/reports-and-presentations

NOTE 8 Reconciliation with financial statements

SEK million 2020
Oct-Dec
2019
Oct-Dec
2020
Jan-Dec
2019
Jan-Dec
Growth/Acquired growth
Net sales growth (%) -1 80 0 82
Of which acquired growth (%) 2 81 4 81
Of which currency effect (%) -3 0 -3 0
Of which organic growth (%) 0 1 -1 1
Operating margin (EBIT)
Net sales 2,764 2,804 11,083 11,040
Operating profit (EBIT) 174 110 717 525
Operating margin, EBIT (%) 6.3 3.9 6.5 4.8
EBITA and adjusted EBITA
Operating profit (EBIT) 174 110 717 525
Amortisation and impairment of intangible assets 27 35 112 125
EBITA 200 145 829 650
Items affecting comparability -0 9 50 138
Adjusted EBITA 200 154 879 788
Net sales 2,764 2,804 11,083 11,040
EBITA margin (%) 7.3 5.2 7.5 5.9
Adjusted EBITA margin (%) 7.3 5.5 7.9 7.1
EBITDA and adjusted EBITDA
Operating profit (EBIT)
174 110 717 525
Depreciation, amortisation and impairment of tangible and intangible assets 228 219 896 845
EBITDA 402 329 1,613 1,370
Items affecting comparability -0 9 50 138
Adjusted EBITDA 402 339 1,663 1,508
EBITDA and adjusted EBITDA excluding IFRS 16
Operating profit (EBIT) 174 110 717 525
Depreciation, amortisation and impairment of tangible and intangible assets 228 219 896 845
Additional: Rental expenses -207 -182 -798 -711
Additional: Capital gain/loss from terminated agreements 0 -3
Net effects of IFRS 16 on EBITDA -207 -182 -802 -711
EBITDA excluding effects of IFRS 16 194 147 811 659
Items affecting comparability -0 9 50 138
Adjusted EBITDA excluding IFRS 16 194 156 861 796
EBITA and adjusted EBITA excluding IFRS 16
Operating profit (EBIT) 174 110 717 525
Amortisation and impairment of intangible assets 27 35 112 125
EBITA 201 145 829 650
Less, amortisation IFRS 16 174 158 682 -618
Additional: Rental expenses -207 -182 -798 711
Additional: Capital gain/loss from terminated agreements 0 -3
Net effects of IFRS 16 on EBITA -33 -24 -120 -94
EBITA excluding effects of IFRS 16 167 121 709 556
Items affecting comparability -0 9 50 138
Adjusted EBITA excluding IFRS 16 167 130 759 694
EBITA margin excluding IFRS 16 6.1 4.3 6.4 5.0
Adjusted EBITA margin excluding IFRS 16 6.1 4.6 6.9 6.3

NOTE 8 Reconciliation with financial statements – continuation

SEK million 2020
Oct-Dec
2019
Oct-Dec
2020
Jan-Dec
2019
Jan-Dec
Operating cash flow
Adjusted EBITDA 402 338 1,663 1,508
Adjustment for non-cash items 0 -38 13 -36
Cash flow from investing activities excl. acquisition and divestment of subsidiaries -28 -24 -122 -110
Adjustment for cash flow from investing activities related to increased capacity/growth 11 13 60 42
Change in working capital 183 273 103 15
Operating cash flow 568 562 1,717 1,418
Cash conversion (%)
Operating cash flow 568 562 1,717 1,418
Adjusted EBITDA 402 338 1,663 1,508
Cash conversion (%) 141.4 166.3 103.2 94.0
Items affecting comparability
Reversal of restructuring and acquisition-related costs
– of which costs included in the line item of consumables -0 0 -0 0
– of which costs included in the line item of other external costs 3 10 32 81
– of which costs included in the line item of personnel costs -3 -1 18 52
– of which costs included in the line item of depreciation, amortisation and impairment 0 0 0 4
Total restructuring and acquisition-related costs 0 9 50 138
Total items affecting comparability -0 9 50 138
SEK million 2020
31 Dec
2019
31 Dec
Net debt, Net debt/Adjusted EBITDA, RTM
Non-current interest-bearing liabilities 5,933 5,131
Current interest-bearing liabilities 2,468 2,838
Less: cash and cash equivalents -25 -52
Net debt 8,375 7,917
Adjusted EBITDA RTM 1,663 1,508
Net debt/Adjusted EBITDA, RTM (times) 5.0 5.3
Net debt, Net debt/Adjusted EBITDA, RTM excl. effects of IFRS 16
Non-current interest-bearing liabilities
5,933 5,131
Less: non-current lease liabilities pertaining to properties recognised on the lease liability line -5,080 -4,134
Current interest-bearing liabilities 2,468 2,838
Less: current lease liabilities pertaining to properties recognised on the lease liability line -623 -571
Less: cash and cash equivalents -25 -52
Net debt excluding effects of IFRS 16 2,672 3,213
Adjusted EBITDA RTM 861 796
Net debt/Adjusted EBITDA, RTM (times) 3.1 4.0

Quality management in the fourth quarter of 2020

Second wave of the coronavirus pandemic

A second wave of COVID-19 affected public health and Ambea in the fourth quarter of 2020. It began in early October, when the number of cases reported in our operations rose rapidly. More cases were reported compared with the situation last spring, especially in Nytida. However, the number of deaths was significantly lower, and was probably due to widespread testing. Several asymptomatic cases were discovered, isolated and treated.

To further prevent transmission between colleagues and protect the residents, we increased the use of personal protective equipment (PPE) during the quarter. For the time being, employees in all of our operations are to wear both a visor and a face mask for their entire shift, even in staff rooms. During the quarter, access to PPE was good.

The head office's support for our operations continued during the quarter in the form of continually updated information and a coronavirus helpline in our three operational countries for managers and qualified employees.

Vaccinations

At the end of the fourth quarter, all divisions began to prepare for the vaccination of care receivers. By the end of January 2021, all of the care receivers in our nursing homes in all countries had received their first jab and many care receivers have now received their second. The vaccination of employees in our operations also commenced.

Care Receiver Surveys

During the quarter, the results of Care Receiver Surveys were presented for Nytida, Stendi and Altiden. Nytida achieved an average score of 88.2 per cent for all questions in the Swedish Association of Local Authorities and Regions (SKR) annual national Care Receiver Survey for target groups in individual and family care and LSS. That is a 0.5 per cent increase year-onyear, and a seal of approval for our care receiver services. Stendi and Altiden conduct their own Care Receiver Surveys and also

achieved positive results: 93 per cent in elderly care and 78 per cent in disability care for Stendi, and 84 per cent for Altiden.

Comprehensive insight training

To ensure quality in Ambea's operations, our managers need to understand and achieve full compliance with Ambea's management system. To support this process, Ambea's Quality Department launched a monthly meeting forum for managers and qualified employees in Sweden during the quarter, to clarify the month's tasks according to the management system and put them in context. A training program is also taking place in Nytida 'Att förstå den röda tråden' (Seeing the big picture), where the various components of the management system are broken down and related to each other through case studies.

New, ambitious emission reduction targets

Ambea wants to challenge and guide the care industry towards lower greenhouse gas emissions. Therefor,in November, Ambea's Board set the target that Ambea will halve its CO2 emissions by 2025, compared with the base year of 2019.

Awards and distinctions

Congratulations to the winners of Ambea's 2020 Quality Award

In December, for the sixth consecutive year, we presented Ambea's quality awards to one operation per division that had excelled in quality management according to our own concepts and models. The aim of the award is to inspire the entire organisation to develop, and to build a sense of commitment and belonging.

The proud winners for 2020 were the Klövedal nursing home (Vardaga), Skarpnäcksgården F-hus HVB facility (Nytida), the Ribstonveien bofelleskap children's home (Stendi) and Altiden Netværk – a residential facility and support network for young people (Altiden). The prizes were presented at a virtual awards ceremony with guests including Ambea's Chairperson and the Chairperson of the Quality and Sustainability Committee.

The quarter in figures

  • The proportion of serious non-compliances (grade 4) in Vardaga and Nytida was 0.1 per cent of the total number of registered non-compliances, which is in line with the preceding Q3 quarter (0.1 per cent). The proportion of serious non-compliances was 0.0 per cent in Stendi, and 0.0 per cent was reported for Altiden.
  • A total of eight individual complaints were submitted to the IVO for investigation in the fourth quarter, of which five were related to Vardaga's operations. The IVO issued a decision on one case with no remarks, decisions are pending for the remaining seven cases. The IVO issued decisions on two previously lodged complaints with no remarks. Three individual complaints were lodged with the IVO regarding Nytida's operations. In the preceding third quarter, five individual complaints were lodged, of which all were related to Vardaga.
  • A total of four Lex Sarah cases were reported, one by Vardaga and three by Nytida. A decision is pending for Vardaga's case. For Nytida, one case has been closed with no remarks and decisions are pending for the remaining two cases.
  • A total of seven Lex Maria cases were reported, four by Vardaga and three by Nytida. Two decisions are pending, and two cases have been closed with no remarks for Vardaga. For Nytida, decisions are pending for all cases.
  • Inspections: The IVO carried out 16 inspections of Nytida's operations. Decisions have been issued with no remarks for seven of these inspections. During the quarter, the Swedish Schools Inspectorate carried out one inspection of Nytida's operations and a decision is pending. There were no inspections of Vardaga's operations (the IVO performed fewer inspections during the pandemic).
  • In Stendi, authorities carried out 40 inspections of the children's units and decisions have been issued for 33 units with no remarks. In children's units in Norway, four inspections per unit are carried out each year.
  • Four regulatory inspections were carried out in Altiden, all of them with no remarks. In Denmark, inspections are graded on a 1-5 point scale, where 5 is the maximum. Altiden achieved an average score of 4.5.

* The Quality and HR Flash is Ambea's tool for monitoring the Group's quality and HR management. It is sent out to all operations every month.